Apolipoprotein A-II Influences Apolipoprotein E-Linked Cardiovascular Disease Risk in Women with High Levels of HDL Cholesterol and C-Reactive Protein

High-Density Lipoprotein Particle Size and Concentration and Coronary Risk

(2013) Karim El Harchaoui   ANNALS OF INTERNAL MEDICINE

Apolipoprotein E predicts incident cardiovascular disease risk in women but not in men with concurrently high levels of high-density lipoprotein cholesterol and C-reactive protein

(2012) James P. Corsetti et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Antiatherogenic Functionality of High Density Lipoprotein: How Much versus How Gooden-subtitle=

(2011) Dmitri Sviridov et al.   Journal of Atherosclerosis and Thrombosis

Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma

(2011) Rong Huang et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Cholesteryl Ester Transfer Protein Polymorphism (TaqIB) Associates With Risk in Postinfarction Patients With High C-Reactive Protein and High-Density Lipoprotein Cholesterol Levels

(2010) James P. Corsetti et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

LPL polymorphism (D9N) predicts cardiovascular disease risk directly and through interaction with CETP polymorphism (TaqIB) in women with high HDL cholesterol and CRP

(2010) James P. Corsetti et al.   ATHEROSCLEROSIS

Apo A-II participates in HDL–liposome interaction by the formation of new pre-β mobility particles and the modification of liposomes

(2010) Małgorzata Wróblewska et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Myeloperoxidase: An Oxidative Pathway for Generating Dysfunctional High-Density Lipoprotein

(2010) Baohai Shao et al.   CHEMICAL RESEARCH IN TOXICOLOGY

Inflammation reduces HDL protection against primary cardiac risk

(2010) James P. Corsetti et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Vitamin D is associated with atheroprotective high-density lipoprotein profile in postmenopausal women

(2010) Rasa Kazlauskaite et al.   Journal of Clinical Lipidology

Low-grade inflammation, and dysfunction of high-density lipoprotein and its apolipoproteins as a major driver of cardiometabolic risk

(2010) Altan Onat et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Human Apolipoprotein A-II Determines Plasma Triglycerides by Regulating Lipoprotein Lipase Activity and High-Density Lipoprotein Proteome

(2009) Josep Julve et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Lipoprotein Particle Profiles by Nuclear Magnetic Resonance Compared With Standard Lipids and Apolipoproteins in Predicting Incident Cardiovascular Disease in Women

(2009) Samia Mora et al.   CIRCULATION

Effects of cholesteryl ester transfer protein inhibition on apolipoprotein A-II-containing HDL subspecies and apolipoprotein A-II metabolism

(2009) Margaret E. Brousseau et al.   JOURNAL OF LIPID RESEARCH

Albuminuria Assessed From First-Morning-Void Urine Samples Versus 24-Hour Urine Collections as a Predictor of Cardiovascular Morbidity and Mortality

(2008) H. J. Lambers Heerspink et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Multiple actions of high-density lipoprotein

(2008) Matilda Florentin et al.   CURRENT OPINION IN CARDIOLOGY

HDL: bridging past and present with a look at the future

(2008) Angelo M. Scanu et al.   FASEB JOURNAL

Apolipoprotein A-II augments monocyte responses to LPS by suppressing the inhibitory activity of LPS-binding protein

(2008) Patricia A. Thompson et al.   Innate Immunity

Beyond High-Density Lipoprotein Cholesterol Levels

(2008) Emil M. deGoma et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

NAD(P)H oxidase polymorphism (C242T) and high HDL cholesterol associate with recurrent coronary events in postinfarction patients

(2007) James P. Corsetti et al.   ATHEROSCLEROSIS